Minimal residual disease (MRD)-guided retreatment with anti-CD20 antibodies effectively lowers MRD levels and delays clinical relapse in patients with high-risk chronic lymphocytic leukemia (CLL), ...

Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges ...

Secura Bio, Inc. ( an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today announced a poster presentation highlighting extended follow up analyses examining ...

Precision-engineered probiotics are emerging as a new frontier in neonatal gut health Genomic tools enable careful strain ...